Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577928 · ClinicalTrials.gov registry record
Value of Fecal Calprotectin
A clinical trial of Inflammatory Bowel Disease and Calprotectin, sponsored by Indiana University.
- Completed
- Registry status
- 171
- Enrollment target
- 1
- Study location
NCT00577928: Completed study of Inflammatory Bowel Disease and Calprotectin, sponsored by Indiana University.
NCT00577928 is a study of Inflammatory Bowel Disease and Calprotectin that has completed, run by Indiana University. The registered enrollment target is 171 participants, below the 398-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577928, a study of Inflammatory Bowel Disease and Calprotectin, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
- 1
- Study location
Study Summary
For the main goal - the accuracy of calprotectin for the diagnosis of IBD - calprotectin levels will be compared between patients with and without a diagnosis of IBD and the sensitivity, specificity and accuracy will be determined. For the secondary aim - the correlation between calprotectin levels and disease activity - in patients with IBD selected from this cohort, we will determine the association between calprotectin levels and clinical IBD score, serological markers (WBC, Hgb, Platelets, ESR, CRP, Albumin), endoscopic (disease score, pathological activity) and radiological features (bowel wall thickening, enhancement, edema, mesenteric inflammation).
Conditions Studied
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-12 |
What the finished NCT00577928 record still lists
NCT00577928 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 398-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00577928 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00577928 about?
NCT00577928 is a clinical study titled "Value of Fecal Calprotectin". For the main goal - the accuracy of calprotectin for the diagnosis of IBD - calprotectin levels will be compared between patients with and without a diagnosis of IBD and the sensitivity, specificity and accuracy will be determined. For the secondary aim - the correlation between calprotectin levels ...
What is the current status of trial NCT00577928?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2006-04. Estimated completion is 2011-12.
What conditions does trial NCT00577928 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease, Calprotectin.
Who is sponsoring clinical trial NCT00577928?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00577928 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00577928's enrollment target sits among peer trials
171 12th of 28 higher than 17 of 28 other Inflammatory Bowel Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Bowel Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
-
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
RECRUITING
-
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia